WallStSmart

Merit Medical Systems Inc (MMSI)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

West Pharmaceutical Services Inc generates 111% more annual revenue ($3.33B vs $1.58B). WST leads profitability with a 17.0% profit margin vs 9.2%. MMSI appears more attractively valued with a PEG of 1.76. WST earns a higher WallStSmart Score of 61/100 (C+).

MMSI

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 6.0Value: 3.3Quality: 7.5
Piotroski: 4/9Altman Z: 2.46

WST

Buy

61

out of 100

Grade: C+

Growth: 6.0Profit: 8.0Value: 2.7Quality: 8.5
Piotroski: 4/9Altman Z: 4.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MMSISignificantly Overvalued (-46.0%)

Margin of Safety

-46.0%

Fair Value

$55.69

Current Price

$85.82

$30.13 premium

UndervaluedFair: $55.69Overvalued
WSTSignificantly Overvalued (-47.9%)

Margin of Safety

-47.9%

Fair Value

$166.45

Current Price

$348.76

$182.31 premium

UndervaluedFair: $166.45Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MMSI1 strengths · Avg: 8.0/10
EPS GrowthGrowth
20.4%8/10

Earnings expanding 20.4% YoY

WST3 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.7310/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.109/10

Conservative balance sheet, low leverage

Operating MarginProfitability
22.5%8/10

Strong operational efficiency at 22.5%

Areas to Watch

MMSI2 concerns · Avg: 4.0/10
PEG RatioValuation
1.764/10

Expensive relative to growth rate

P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

WST3 concerns · Avg: 2.7/10
Price/BookValuation
8.3x4/10

Trading at 8.3x book value

PEG RatioValuation
2.912/10

Expensive relative to growth rate

P/E RatioValuation
43.5x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : MMSI

The strongest argument for MMSI centers on EPS Growth.

Bull Case : WST

The strongest argument for WST centers on Altman Z-Score, Debt/Equity, Operating Margin. Profitability is solid with margins at 17.0% and operating margin at 22.5%. Revenue growth of 13.8% demonstrates continued momentum.

Bear Case : MMSI

The primary concerns for MMSI are PEG Ratio, P/E Ratio.

Bear Case : WST

The primary concerns for WST are Price/Book, PEG Ratio, P/E Ratio. A P/E of 43.5x leaves little room for execution misses.

Key Dynamics to Monitor

MMSI profiles as a value stock while WST is a mature play — different risk/reward profiles.

WST carries more volatility with a beta of 1.16 — expect wider price swings.

WST is growing revenue faster at 13.8% — sustainability is the question.

WST generates stronger free cash flow (81M), providing more financial flexibility.

Bottom Line

WST scores higher overall (61/100 vs 54/100), backed by strong 17.0% margins and 13.8% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Merit Medical Systems Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?